IRIS
TONIUTTO, Pierluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.399
AS - Asia 5.785
EU - Europa 4.233
SA - Sud America 1.078
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 5
Totale 26.625
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.166
SG - Singapore 2.939
CN - Cina 1.162
UA - Ucraina 1.057
BR - Brasile 891
DE - Germania 800
HK - Hong Kong 646
IT - Italia 432
FI - Finlandia 372
RU - Federazione Russa 349
VN - Vietnam 339
SE - Svezia 326
IE - Irlanda 238
TR - Turchia 226
FR - Francia 207
GB - Regno Unito 180
CA - Canada 131
IN - India 109
KR - Corea 100
AR - Argentina 76
MX - Messico 65
PL - Polonia 54
BE - Belgio 45
BD - Bangladesh 38
IR - Iran 37
AT - Austria 36
ZA - Sudafrica 34
EC - Ecuador 33
JP - Giappone 30
ES - Italia 29
IQ - Iraq 28
ID - Indonesia 23
NL - Olanda 23
PK - Pakistan 21
EU - Europa 19
PY - Paraguay 19
CO - Colombia 18
CZ - Repubblica Ceca 13
VE - Venezuela 13
MA - Marocco 12
CL - Cile 11
LT - Lituania 11
UZ - Uzbekistan 11
KE - Kenya 10
CH - Svizzera 9
TG - Togo 9
AZ - Azerbaigian 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
GR - Grecia 7
SA - Arabia Saudita 7
AO - Angola 6
DZ - Algeria 6
DO - Repubblica Dominicana 5
EE - Estonia 5
ET - Etiopia 5
HN - Honduras 5
NI - Nicaragua 5
BH - Bahrain 4
BO - Bolivia 4
DK - Danimarca 4
JO - Giordania 4
LK - Sri Lanka 4
NP - Nepal 4
PA - Panama 4
PS - Palestinian Territory 4
TW - Taiwan 4
AL - Albania 3
AM - Armenia 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
HR - Croazia 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
LI - Liechtenstein 3
NO - Norvegia 3
PH - Filippine 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BB - Barbados 2
CI - Costa d'Avorio 2
IL - Israele 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
XK - ???statistics.table.value.countryCode.XK??? 2
BY - Bielorussia 1
Totale 26.597
Salva come PNG Salva come JPEG
Città #
Fairfield 1.862
Woodbridge 1.800
Ashburn 1.273
Singapore 1.102
Ann Arbor 1.043
Houston 1.015
Chandler 1.002
Seattle 767
Wilmington 737
Jacksonville 704
Hong Kong 643
Cambridge 637
Beijing 561
Dearborn 463
Boardman 312
Princeton 229
Udine 228
Munich 226
Dublin 225
Los Angeles 206
Izmir 173
Ho Chi Minh City 132
Hefei 119
Helsinki 109
New York 99
Dallas 95
Buffalo 93
San Diego 88
Seoul 86
Redondo Beach 85
São Paulo 80
Hanoi 67
Ottawa 67
Des Moines 50
Nuremberg 45
Warsaw 45
Brussels 40
Mumbai 40
Mexico City 35
Norwalk 35
Kunming 34
Ogden 34
Falls Church 30
The Dalles 30
Nanjing 28
Tokyo 28
Frankfurt am Main 26
Denver 25
Leawood 25
Phoenix 25
Rio de Janeiro 25
Montreal 22
Shanghai 22
Dong Ket 21
Guangzhou 21
San Francisco 21
Vienna 21
Brooklyn 20
Stockholm 20
Orem 19
Toronto 18
Da Nang 17
Düsseldorf 17
San Mateo 17
Santa Clara 17
Johannesburg 16
Washington 16
Zanjan 16
Atlanta 15
Belo Horizonte 15
Chicago 15
Chongqing 15
Jinan 15
Chennai 14
London 14
Manchester 14
Poplar 14
San Jose 14
Zhengzhou 14
Augusta 13
Turku 13
Amsterdam 12
Ankara 12
Baghdad 12
Belluno 12
Guarulhos 12
Trieste 12
Boston 11
Council Bluffs 11
Grafing 11
Hangzhou 11
Hebei 11
Milan 11
Nanchang 11
Querétaro 11
Quito 11
Tashkent 11
Dhaka 10
Goiânia 10
Wuhan 10
Totale 17.646
Salva come PNG Salva come JPEG
Nome #
Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. 226
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: Evidence against a cause-effect relationship 225
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 218
Increase of Serum aú1-Acid Glycoprotein Despite the Decline of Liver Synthetic Function in Cirrhotics with Hepatocellular Carcinoma 214
A single-center experience of late retransplantation of the liver. 212
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 208
Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF). 207
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 206
Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C 199
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 199
Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C. 192
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 191
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 186
Intensity of inflammatory damage and serum lipid peroxide concentrations in liver disease 180
Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases. 177
PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis 177
Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver-transplanted patients. 175
Liver transplantation from old donors into HCV and non-HCV recipients 175
Management of infections in cirrhotic patients: report of a consensus conference. 174
Toll Like Receptor 4 D299G Associates with Disease Progression in Caucasian Patients with Chronic HBV Infection: Relationship with Gender. 169
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases. 169
A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis 169
Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype. 167
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. 166
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 161
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome. 160
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C. 159
Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy 159
Mild sialoadenitis: a common finding in patients with hepatitis C virus infection 159
Serum soluble vascular-cell adhesion molecule-1 (VCAM-1) in patients with acute and chronic liver diseases 159
Clinical and virologic response to entecavir in HBV related chronic hepatitis or cirrhosis: data from the clinical practice in a single centre cohort. 158
Degree of bile-duct dilatation in liver-transplanted patients with biliary stricture: a magnetic resonance cholangiography-based study. 156
Circulating intercellular adhesion molecule-1 (cICAM-1) concentration in liver disease. Relationship with cholestasis and functioning hepatic mass. 155
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 154
Changes in blood lipid composition and response to interferon treatment in chronic hepatitis C 153
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 153
Biliary strictures after liver transplantation: Role of interleukin 28B genotypes in cyclosporine treated 152
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. 151
Specific issues concerning the management of patients on the waiting list and after liver transplantation 150
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts. 149
Quality-of-life assessment before and after liver transplantation. 149
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial 149
Impact of magnetic resonance cholangiography in managing liver-transplanted patients: preliminary results of a clinical decision-making study 149
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 148
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 148
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. 147
Acute alcoholic hepatitis and liver transplantation: Waiting for Godot 147
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E e4 carriers: relationship with the blood lipid profile 147
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 146
Consensus conference on TIPS management: Techniques, indications, contraindications 145
Weight gain after liver transplantation and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene 144
GENE POLYMORPHISM AT THE INTERLEUKIN 6 -174 G > C LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 144
INFLUENCE OF ANGIOTENSIN-CONVERTING ENZYME I/D GENE POLYMORPHISM ON CLINICAL AND HISTOLOGICAL CORRELATES OF CHRONIC HEPATITIS C 144
Hepatic release of erythropoietin induced by transarterial chemoembolization in patients with hepatocellular carcinoma. 143
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 143
Evidence for a multifactorial control of serum erythropoietin concentration in liver disease 142
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 141
DIFFUSION-WEIGHTED MRI IN EVALUATING LIVER FIBROSIS: A FEASIBILITY STUDY IN CIRRHOTIC PATIENTS 141
Favourable Outcome of Adefovir-Dipivoxil Treatment in Acute de Novo Hepatitis B After Liver Transplantation 141
Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome. 140
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C 140
A study on role of the family and other risk factors in HCV transmission 140
Thrombocytopenia of chronic liver disease corrected by erythropoietin treatment 140
Occult hepatitis B virus infection in peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia. 140
Diagnostic usefulness of acute-phase protein measurement in hepatocellular carcinoma. 139
Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy. 138
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 138
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. 137
Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation 137
Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease 137
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 136
Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation 135
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 135
Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis 134
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used. 133
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 133
Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules. 133
Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection. 133
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 132
Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end stage liver disease 132
IgM antibody response to the hepatitis C virus core protein in intravenous drug users. 130
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 130
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 130
Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review 130
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C. 129
Vitamin D and the risk of acute allograft rejection following human liver transplantation. 129
HUMAN LEUKOCYTE ANTIGEN POLYMORPHISMS IN ITALIAN PRIMARY BILIARY CIRRHOSIS: A MULTICENTER STUDY OF 664 PATIENTS AND 1992 HEALTHY CONTROLS 129
Antiviral treatment of hepatitis C 129
Factors associated with serum HCV RNA positivity in anti HCV antibody positive intravenous drug users 128
Chronic sialoadenitis associated with HCV-related liver disease: differences in comparison to Sjogren syndrome 128
Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship. 127
Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B 127
Antiviral treatment in patients with hepatitis C virus related cirrhosis awaiting liver transplantation 126
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study. 126
Vitamin D deficiency and HCV chronic infection: what comes first? 125
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 125
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers. 125
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "blended Principle Model" 125
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. 125
Reliability and reproducibility of the Edmonson grading of hepatocellular carcinoma using paired core biopsy and surgical resection specimens 124
Totale 15.236
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.264
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.894 0 0 0 0 0 419 174 290 370 110 362 169
2021/20221.861 81 149 112 110 27 104 108 97 32 278 479 284
2022/20232.254 259 167 35 304 229 580 1 174 339 25 79 62
2023/2024674 132 78 32 18 138 97 15 33 58 38 10 25
2024/20254.680 100 289 145 172 141 311 304 339 570 361 743 1.205
2025/20264.742 645 923 733 710 1.328 403 0 0 0 0 0 0
Totale 27.129